Valuation (50%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 151.21 | N/A |
| PEG Ratio (TTM) | -2.04 | N/A |
| P/S Ratio (TTM) | 0.28 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 6.29 | N/A |
| Price to 5YR AVG Earnings Ratio | -4.94 | N/A |
| Price to 5YR AVG FCF Ratio | 4.52 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.18% | N/A |
| ROE (TTM) | 0.82% | N/A |
| Net Profit Margin (TTM) | 0.18% | N/A |
| ROIC 5YR AVG | 5.75% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.55% | 47.79% | 15.19% |
| Revenue | -1.43% | -7.79% | -7.99% |
| Net Income | 0.98% | 54.27% | 20.01% |
| Cash Flow | 22.82% | 349.19% | 207.60% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.25 | N/A |
| Quick Ratio (TTM) | 1.25 | N/A |
| D/E Ratio (TTM) | 1.24 | N/A |
| Interest Coverage (TTM) | 2.32 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.98 | N/A |
| LTL to 5YR AVG FCF | 5.34 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.62% | N/A |